ArticleArchives of craniofacial surgery2025
The potential use of hydroxyapatite from sea coral as a bone substitute: a systematic review.
Article in Archives of craniofacial surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBone defects can result from trauma, neoplasms, infections, or congenital anomalies. A common strategy for managing these defects is bone grafting, which must meet three essential biological requirements: osteoconductivity, osteogenicity, and osteoinductivity. Bone graft materials may be sourced from either natural or synthetic origins. Among natural materials, hydroxyapatite derived from marine coral has attracted attention as a bioceramic due to its compositional similarity to the mineral phase of human bone.
methodsCoral-derived hydroxyapatite primarily serves as an osteoconductive scaffold, supporting the attachment, proliferation, and differentiation of stem cells and osteoblasts. This process facilitates bone regeneration and the formation of new bone tissue. Additionally, coral hydroxyapatite may contribute to osteoinduction by stimulating local stem cells and osteoblasts, thus promoting osteogenesis and enhancing bone healing.
resultsOwing to these properties, coral hydroxyapatite is considered a promising material for encouraging bone regeneration in defect sites.
conclusionHydroxyapatite obtained from marine coral represents a viable and effective bone graft substitute for reconstructing bone defects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.